Internet of Things - IOT

This deliverable provides insights on the many macro issues facing the pharma and biotech industry. The industry is currently in a state of transition and is faced with a myraid of challenges including the dreaded patent cliff. This research service presents a total market forecast, market share analysis by leading companies, top therapeutic class...

This research analyses the current and future economic trends and its impact on the pumps market in global biotech industry. The applications have been analysed across the globe and also a growth trend based on the three broad product classifications has been provided. The mega drivers with their corresponding implementation time have been discusse...

This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...

This briefing from the beginning of 2010 is on macro level dynamics in the global pharmaceutical and biotechnology industry. It is being made available for the value of our subscribers.

This market insight on contract sales and marketing organisations throws light on the changing dynamics and the opportunities that lie ahead for these organisations in the future.

This issue of Vital Signs, released on May 18, 2009, provides a strategic overview of opportunities and issues in the pharmaceutical and biotechnology outsourcing services markets. Additionally, a company spotlight is provided for Aerie Pharmaceuticals, an emerging pharma company focused on glaucoma. Reimbursement and regulatory news from the FDA i...

Japan is emerging as a force to reckon with in the global biotechnology landscape. Lately, committed support from the government and resulting administrative changes have brought the Japanese biotech industry to an inflection point. There are plenty of opportunities for Japanese biotech companies to explore and fewer hurdles on their path compared ...

South Korean biotechnology industry is poised to become an important biotechnology hub in Asia Pacific region. Strong government support, well developed infrastructure, and increasing scientific pool have created a positive environment for growth of industry. The private sector too has realized the growing importance of participation. Many biotech ...